Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sisram Medical Ltd. ( (HK:1696) ) just unveiled an announcement.
Sisram Medical Ltd has announced the composition of its board of directors effective from January 1, 2026. The board includes a mix of executive, non-executive, and independent non-executive directors, with Mr. Lior Moshe Dayan serving as Chairman. This announcement is significant for stakeholders as it outlines the leadership structure that will guide the company’s strategic direction and governance.
The most recent analyst rating on (HK:1696) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on Sisram Medical Ltd. stock, see the HK:1696 Stock Forecast page.
More about Sisram Medical Ltd.
Sisram Medical Ltd, incorporated in Israel, operates in the medical industry. The company focuses on providing advanced medical solutions and technologies.
Average Trading Volume: 722,725
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.97B
Find detailed analytics on 1696 stock on TipRanks’ Stock Analysis page.